From this retrospective single center analysis adults with acute lymphoblastic leukemia transplanted in > or 2nd CR from an HLA-identical sibling later than 1993 had a worse outcome. As the transplanted-related mortality improved by time,this result was essentially due to the increased relapse rate. The intensity of the pre-transplant salvage chemotherapy was identified as the main factor influencing the post-transplant relapse-risk
International audienceAllogeneic hematopoietic cell transplantation is widely used to treat adults w...
Allogeneic hematopoietic SCT (allo-SCT) is a promising therapy that may provide long-term durable re...
Patients with acute myeloid leukemia (AML) who relapse after autologous stem cell transplantation (A...
From this retrospective single center analysis adults with acute lymphoblastic leukemia transplanted...
To describe outcomes, treatment and prognostic factors that influence survival of adult patients wit...
AbstractFor patients with acute lymphoblastic leukemia (ALL) who relapse after allogeneic hematopoie...
Because information on management and outcome of AML relapse after allogeneic hematopoietic stem cel...
AbstractThe aim of the present study was to identify graft-versus-leukemia effects and the factors t...
A retrospective analysis identified 161 consecutive adults with acute lymphoblastic leukemia who und...
International audiencePurpose: Relapse after allogeneic hematopoietic cell transplantation (allo-HCT...
BackgroundAs information on incidence, risk factors, and outcome of acute leukemia (AL) relapse afte...
To evaluate the results of autologous stem cell transplantation ( ASCT) in a large population of adu...
Allogeneic hematopoietic cell transplantation is widely used to treat adults with high-risk acute ly...
International audienceAllogeneic hematopoietic cell transplantation is widely used to treat adults w...
Allogeneic hematopoietic SCT (allo-SCT) is a promising therapy that may provide long-term durable re...
Patients with acute myeloid leukemia (AML) who relapse after autologous stem cell transplantation (A...
From this retrospective single center analysis adults with acute lymphoblastic leukemia transplanted...
To describe outcomes, treatment and prognostic factors that influence survival of adult patients wit...
AbstractFor patients with acute lymphoblastic leukemia (ALL) who relapse after allogeneic hematopoie...
Because information on management and outcome of AML relapse after allogeneic hematopoietic stem cel...
AbstractThe aim of the present study was to identify graft-versus-leukemia effects and the factors t...
A retrospective analysis identified 161 consecutive adults with acute lymphoblastic leukemia who und...
International audiencePurpose: Relapse after allogeneic hematopoietic cell transplantation (allo-HCT...
BackgroundAs information on incidence, risk factors, and outcome of acute leukemia (AL) relapse afte...
To evaluate the results of autologous stem cell transplantation ( ASCT) in a large population of adu...
Allogeneic hematopoietic cell transplantation is widely used to treat adults with high-risk acute ly...
International audienceAllogeneic hematopoietic cell transplantation is widely used to treat adults w...
Allogeneic hematopoietic SCT (allo-SCT) is a promising therapy that may provide long-term durable re...
Patients with acute myeloid leukemia (AML) who relapse after autologous stem cell transplantation (A...